In participants with overweight or obesity, once-daily oral semaglutide 25 mg treatment compared with placebo led to greater improvements in glycemic parameters, including HbA1c, fasting plasma glucose, and fasting serum insulin, as well as CV risk factors such as C-reactive protein and serum triglycerides
Stopping without these conditions in place significantly increases regain risk and may cause rapid hunger rebound that destabilizes your progress
[39:55] I think it's important to be in a good temperature environment for sleep
The blood vessel constructs were characterized morphologically and structurally by Fourier Transform Infrared (FTIR) Spectroscopy, thermogravimetric analysis (TGA), Scanning Electron Microscopy (SEM), immunohistochemistry, water uptake, and enzymatic degradation
You can find both of these products on my Amazon storefront located in my bio